Intermittent hypoxia‐induced epiregulin expression by IL‐6 production in human coronary artery smooth muscle cells.
- Published in:
- FEBS Open Bio, 2018, v. 8, n. 5, p. 868, doi. 10.1002/2211-5463.12430
- By:
- Publication type:
- Article
Works matching IS 22115463 AND DT 2018 AND VI 8 AND IP 5
Results: 16
1
2
Gene expression profiles and pathway enrichment analysis of human osteosarcoma cells exposed to sorafenib.
- Published in:
- FEBS Open Bio, 2018, v. 8, n. 5, p. 860, doi. 10.1002/2211-5463.12428
- By:
- Publication type:
- Article
3
The involvement of 4‐1BB/4‐1BBL signaling in glial cell‐mediated hypothalamic inflammation in obesity.
- Published in:
- FEBS Open Bio, 2018, v. 8, n. 5, p. 843, doi. 10.1002/2211-5463.12426
- By:
- Publication type:
- Article
4
FGF‐2 suppresses expression of nephronectin via JNK and PI3K pathways.
- Published in:
- FEBS Open Bio, 2018, v. 8, n. 5, p. 836, doi. 10.1002/2211-5463.12421
- By:
- Publication type:
- Article
5
A noncanonical function of histidyl‐tRNA synthetase: inhibition of vascular hyperbranching during zebrafish development.
- Published in:
- FEBS Open Bio, 2018, v. 8, n. 5, p. 722, doi. 10.1002/2211-5463.12420
- By:
- Publication type:
- Article
6
Anticancer activity of the protein kinase C modulator HMI‐1a3 in 2D and 3D cell culture models of androgen‐responsive and androgen‐unresponsive prostate cancer.
- Published in:
- FEBS Open Bio, 2018, v. 8, n. 5, p. 817, doi. 10.1002/2211-5463.12419
- By:
- Publication type:
- Article
7
Kinetic contribution to extracellular Na<sup>+</sup>/K<sup>+</sup> selectivity in the Na<sup>+</sup>/K<sup>+</sup> pump.
- Published in:
- FEBS Open Bio, 2018, v. 8, n. 5, p. 854, doi. 10.1002/2211-5463.12418
- By:
- Publication type:
- Article
8
Identification of small‐molecule elastase inhibitors as antagonists of IL‐36 cytokine activation.
- Published in:
- FEBS Open Bio, 2018, v. 8, n. 5, p. 751, doi. 10.1002/2211-5463.12406
- By:
- Publication type:
- Article
9
Plasma anti‐BIRC5 IgG may be a useful marker for evaluating the prognosis of nonsmall cell lung cancer.
- Published in:
- FEBS Open Bio, 2018, v. 8, n. 5, p. 829, doi. 10.1002/2211-5463.12417
- By:
- Publication type:
- Article
10
Comparative metabolomics and glycolysis enzyme profiling of embryogenic and nonembryogenic grape cells.
- Published in:
- FEBS Open Bio, 2018, v. 8, n. 5, p. 784, doi. 10.1002/2211-5463.12415
- By:
- Publication type:
- Article
11
Isolation of native plasma membrane H<sup>+</sup>‐ATPase (Pma1p) in both the active and basal activation states.
- Published in:
- FEBS Open Bio, 2018, v. 8, n. 5, p. 774, doi. 10.1002/2211-5463.12413
- By:
- Publication type:
- Article
12
Loss of scinderin decreased expression of epidermal growth factor receptor and promoted apoptosis of castration‐resistant prostate cancer cells.
- Published in:
- FEBS Open Bio, 2018, v. 8, n. 5, p. 743, doi. 10.1002/2211-5463.12412
- By:
- Publication type:
- Article
13
Poly(rC) binding protein 2 (PCBP2) promotes the viability of human gastric cancer cells by regulating CDK2.
- Published in:
- FEBS Open Bio, 2018, v. 8, n. 5, p. 764, doi. 10.1002/2211-5463.12408
- By:
- Publication type:
- Article
14
Synergistic effects of HMG‐CoA reductase inhibitor and angiotensin II receptor blocker on load‐induced heart failure.
- Published in:
- FEBS Open Bio, 2018, v. 8, n. 5, p. 799, doi. 10.1002/2211-5463.12416
- By:
- Publication type:
- Article
15
Dasatinib promotes TRAIL‐mediated apoptosis by upregulating CHOP‐dependent death receptor 5 in gastric cancer.
- Published in:
- FEBS Open Bio, 2018, v. 8, n. 5, p. 732, doi. 10.1002/2211-5463.12404
- By:
- Publication type:
- Article
16
Issue Information.
- Published in:
- FEBS Open Bio, 2018, v. 8, n. 5, p. 719, doi. 10.1002/2211-5463.12291
- Publication type:
- Article